Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
HOFF, Paulo M, ANSARI, Rafat, BURGER, Hans U, OSTERWALDER, Bruno, WONG, Alfred O, WONG, Ralf, BATIST, Gerald, COX, John, KOCHA, Walter, KUPERMINC, Mario, MAROUN, Jean, WALDE, David, WEAVER, Charles, HARRISON, Evelyn
Published in Journal of clinical oncology (15.04.2001)
Published in Journal of clinical oncology (15.04.2001)
Get full text
Journal Article
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
BLUM, J. L, JONES, S. E, BUZDAR, A. U, LORUSSO, P. M, KUTER, I, VOGEL, C, OSTERWALDER, B, BURGER, H.-U, BROWN, C. S, GRIFFIN, T
Published in Journal of clinical oncology (01.02.1999)
Published in Journal of clinical oncology (01.02.1999)
Get full text
Journal Article
Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity
Segota, Ena, M.D, Mekhail, Tarek, M.D, Olencki, Thomas, D.O, Hutson, Thomas E., D.O, Dreicer, Robert, M.D, Wacker, Brenda, R.N, Osterwalder, Bruno, M.D, Elson, Paul, Sc.D, Zhou, Ming, M.D, Bukowski, Ronald M., M.D
Published in Urologic oncology (2007)
Published in Urologic oncology (2007)
Get full text
Journal Article
Translational Medicine Guide transforms drug development processes: the recent Merck experience
Dolgos, Hugues, Trusheim, Mark, Gross, Dietmar, Halle, Joern-Peter, Ogden, Janet, Osterwalder, Bruno, Sedman, Ewen, Rossetti, Luciano
Published in Drug discovery today (01.03.2016)
Published in Drug discovery today (01.03.2016)
Get full text
Journal Article
Abstract CT073: IMPRIME 1 (NCT02981303): A novel phase 2 study in second-line +, metastatic triple negative breast cancer patients shows promising clinical benefit for the combination of the immune checkpoint inhibitor, pembrolizumab (pembro), with the novel innate immune activator, Imprime PGG
O'Day, Steven J., Borges, Virginia F., Chmielowski, Bartosz, Rao, Ruta D., Abu-Khalaf, Maysa, Stopeck, Alison, O'Shaughnessy, Joyce A., Chisamore, Michael, Karantza, Vassiliki, Cox, Joanna, Mattson, Paulette, Gargano, Michele A., Osterwalder, Bruno, Uhlik, Mark, Bose, Nandita, Graff, Jeremy
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract PD1-02: Response and clinical benefit assessment of the combination of the dectin-1 agonist imprime PGG and anti-PD-1 pembrolizumab in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)
Uhlik, Mark T, Bose, Nandita, Cox, Joanna, Mattson, Paulette, Gargano, Michele, O'Day, Stephen, Borges, Virginia, Chmielowski, Bartosz, Rao, Ruta, Abu-Khalaf, Maysa, Stopeck, Alison, Chisamore, Michael, Osterwalder, Bruno, Graff, Jeremy
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract LB-129: Imprime PGG, a soluble yeast β-glucan PAMP, in combination with Pembrolizumab induces infiltration and activation of both innate and adaptive immune cells within tumor sites in melanoma and triple-negative breast cancer (TNBC) patients
Uhlik, Mark T., Harrison, Ben, Gorden, Keith, Leonardo, Steven, Walsh, Richard, Ertelt, Kathleen, Gargano, Michele, Chisamore, Michael, Lowe, Jamie, Osterwalder, Bruno, Bose, Nandita, Graff, Jeremy
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
An open label, multicenter phase II study combining imprime PGG (PGG) with pembrolizumab ( P ) in previously treated metastatic triple-negative breast cancer (mTNBC)
O'Day, Steven, Borges, Virginia F., Chmielowski, Bartosz, Rao, Ruta D., Abu-Khalaf, Maysa M., Stopeck, Alison, Nikolinakos, Petros, Telli, Melinda L., Xie, Bin, Shaheen, Montaser F., Mattson, Paulette, Gargano, Michele Anne, Cox, Joanna, Karantza, Vassiliki, Chisamore, Michael Jon, Osterwalder, Bruno, Bose, Nandita, Uhlik, Mark T., Graff, Jeremy
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Abstract LB-A31: Imprime PGG (Imprime) plus pembrolizumab (PEM): a phase 2 immunotherapeutic combination in patients selected for an Imprime-specific biomarker
O'Day, Steven, Bose, Nandita, Uhlik, Mark, Prathikanti, Radha, Harrison, Ben, Leonardo, Steven, Huhn, Richard, Ottoson, Nadine, Qiu, Xiaohong, Walsh, Richard, Mattson, Paulette, Ma, Mable, Ertelt, Katie, Lowe, Jamie, Gargano, Michele A., Chisamore, Michael, Osterwalder, Bruno, Graff, Jeremy
Published in Molecular cancer therapeutics (01.01.2018)
Published in Molecular cancer therapeutics (01.01.2018)
Get full text
Journal Article
Hepcidin as a Predictor of Response to Epoetin Therapy in Anemic Cancer Patients
Ukarma, Lidia, Johannes, Helene, Beyer, Ulrich, Zaug, Michel, Osterwalder, Bruno, Scherhag, Armin
Published in Clinical chemistry (Baltimore, Md.) (01.07.2009)
Published in Clinical chemistry (Baltimore, Md.) (01.07.2009)
Get full text
Journal Article
What is the impact of antithrombotic therapy and risk factors on the frequency of thrombovascular events in patients with metastatic breast cancer receiving epoetin beta?
Aapro, Matti, Barnadas, Agustí, Leonard, Robert C, Marangolo, Maurizio, Untch, Michael, Ukarma, Lidia, Burger, Hans-Ulrich, Scherhag, Armin, Osterwalder, Bruno
Published in European journal of cancer (1990) (01.11.2009)
Published in European journal of cancer (1990) (01.11.2009)
Get full text
Journal Article
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine
Budman, D R, Meropol, N J, Reigner, B, Creaven, P J, Lichtman, S M, Berghorn, E, Behr, J, Gordon, R J, Osterwalder, B, Griffin, T
Published in Journal of clinical oncology (01.05.1998)
Published in Journal of clinical oncology (01.05.1998)
Get more information
Journal Article
Chemotherapy for metastatic breast cancer–report of a European expert panel
Crown, John, Diéras, Véronique, Kaufmann, Manfred, von Minckwitz, Gunter, Kaye, Stan, Leonard, Robert, Marty, Michel, Misset, Jean-Louis, Osterwalder, Bruno, Piccart, Martine
Published in The lancet oncology (01.12.2002)
Published in The lancet oncology (01.12.2002)
Get full text
Journal Article
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients
REIGNER, B, VERWEIJ, J, OSTERWALDER, B, DIRIX, L, CASSIDY, J, TWELVES, C, ALLMAN, D, WEIDEKAMM, E, ROOS, B, BANKEN, L, UTOH, M
Published in Clinical cancer research (01.04.1998)
Get full text
Published in Clinical cancer research (01.04.1998)
Journal Article
Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity
Segota, Ena, Mekhail, Tarek, Olencki, Thomas, Hutson, Thomas E, Dreicer, Robert, Wacker, Brenda, Osterwalder, Bruno, Elson, Paul, Zhou, Ming, Bukowski, Ronald M
Published in Urologic oncology (01.01.2007)
Published in Urologic oncology (01.01.2007)
Get full text
Journal Article
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics
CHANG, David Z, OLENCKI, Thomas, BUDD, G. Thomas, PEEREBOOM, David, GANAPATHI, R, OSTERWALDER, Bruno, BUKOWSKI, Ronald
Published in Cancer chemotherapy and pharmacology (01.12.2001)
Published in Cancer chemotherapy and pharmacology (01.12.2001)
Get full text
Journal Article
Delayed Alloimmunization Using Random Single Donor Platelet Transfusions: A Prospective Study in Thrombocytopenic Patients With Acute Leukemia
Gmür, Jürg, von Feiten, Arthur, Osterwalder, Bruno, Honegger, Hanspeter, Hörmann, Andreas, Sauter, Christian, Deubelbeiss, Kurt, Berchtold, Willi, Metaxas, Marc, Scali, Giancarlo, Frick, Paul G.
Published in Blood (01.08.1983)
Published in Blood (01.08.1983)
Get full text
Journal Article